TY - JOUR
T1 - Three cases of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas
AU - Shirakawa, Hiroshi
AU - Kikuchi, Eiji
AU - Mikami, Shuji
AU - Fukamachi, Shigeru
AU - Miyazaki, Yasumasa
AU - Tanaka, Nobuyuki
AU - Miyajima, Akira
AU - Oya, Mototsugu
PY - 2012/4
Y1 - 2012/4
N2 - This report presents three cases of urinary upper tract carcinomas producing granulocyte colony-stimulating factor (G-CSF), with high blood leukocyte counts and poor prognoses. Case 1 was a 73-year-old man who underwent nephroureterectomy for left renal pelvic carcinoma. Pathologically, urothelial carcinoma (UC), high-grade, was observed, and immunohistochemical analysis showed positive staining for G-CSF. Progressive disease (PD) was observed despite administration of systemic chemotherapy for disease relapse, and the patient died 4.5 months after the operation. Case 2 was a 74-year-old man who had left renal pelvic carcinoma with para-aortic lymph-node metastases. The serum G-CSF was elevated (169 pg/ml). The patient refused any aggressive treatment, and died 2.3 months after his first visit to the hospital. Case 3 was a 75-year-old woman who had left renal pelvic carcinoma with adrenal metastasis. Biopsy confirmed the diagnosis as UC with squamous differentiation, and the serum G-CSF was elevated (138 pg/ml). Systemic chemotherapy was administered. However, the patient showed PD, and died 6.9 months after her first visit to the hospital. Effective treatment strategies are warranted for carcinomas producing G-CSF. Elucidation of the actions of G-CSF on both the carcinoma cells and the tumor microenvironment may contribute to the development of useful strategies.
AB - This report presents three cases of urinary upper tract carcinomas producing granulocyte colony-stimulating factor (G-CSF), with high blood leukocyte counts and poor prognoses. Case 1 was a 73-year-old man who underwent nephroureterectomy for left renal pelvic carcinoma. Pathologically, urothelial carcinoma (UC), high-grade, was observed, and immunohistochemical analysis showed positive staining for G-CSF. Progressive disease (PD) was observed despite administration of systemic chemotherapy for disease relapse, and the patient died 4.5 months after the operation. Case 2 was a 74-year-old man who had left renal pelvic carcinoma with para-aortic lymph-node metastases. The serum G-CSF was elevated (169 pg/ml). The patient refused any aggressive treatment, and died 2.3 months after his first visit to the hospital. Case 3 was a 75-year-old woman who had left renal pelvic carcinoma with adrenal metastasis. Biopsy confirmed the diagnosis as UC with squamous differentiation, and the serum G-CSF was elevated (138 pg/ml). Systemic chemotherapy was administered. However, the patient showed PD, and died 6.9 months after her first visit to the hospital. Effective treatment strategies are warranted for carcinomas producing G-CSF. Elucidation of the actions of G-CSF on both the carcinoma cells and the tumor microenvironment may contribute to the development of useful strategies.
KW - Granulocyte colony-stimulating factor
KW - Renal pelvic carcinoma
KW - Urothelial carcinoma
UR - http://www.scopus.com/inward/record.url?scp=84858392484&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84858392484&partnerID=8YFLogxK
U2 - 10.3109/00365599.2011.644863
DO - 10.3109/00365599.2011.644863
M3 - Article
C2 - 22251056
AN - SCOPUS:84858392484
SN - 2168-1805
VL - 46
SP - 136
EP - 141
JO - Scandinavian Journal of Urology
JF - Scandinavian Journal of Urology
IS - 2
ER -